rs2476491

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000417.3(IL2RA):​c.64+8641T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.246 in 152,188 control chromosomes in the GnomAD database, including 5,213 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.25 ( 5213 hom., cov: 32)

Consequence

IL2RA
NM_000417.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.604

Publications

29 publications found
Variant links:
Genes affected
IL2RA (HGNC:6008): (interleukin 2 receptor subunit alpha) The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency. Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma. Similarly, serum IL-2R levels are found to be elevated in patients with different types of carcinomas. Certain IL2RA and IL2RB gene polymorphisms have been associated with lung cancer risk. [provided by RefSeq, Jul 2020]
IL2RA Gene-Disease associations (from GenCC):
  • immunodeficiency due to CD25 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • neonatal diabetes mellitus with congenital hypothyroidism
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • type 1 diabetes mellitus 10
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.299 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL2RANM_000417.3 linkc.64+8641T>A intron_variant Intron 1 of 7 ENST00000379959.8 NP_000408.1 P01589
IL2RANM_001308242.2 linkc.64+8641T>A intron_variant Intron 1 of 6 NP_001295171.1 P01589Q5W005
IL2RANM_001308243.2 linkc.64+8641T>A intron_variant Intron 1 of 5 NP_001295172.1 P01589H0Y5Z0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL2RAENST00000379959.8 linkc.64+8641T>A intron_variant Intron 1 of 7 1 NM_000417.3 ENSP00000369293.3 P01589

Frequencies

GnomAD3 genomes
AF:
0.246
AC:
37448
AN:
152070
Hom.:
5211
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.164
Gnomad AMI
AF:
0.240
Gnomad AMR
AF:
0.257
Gnomad ASJ
AF:
0.424
Gnomad EAS
AF:
0.0219
Gnomad SAS
AF:
0.210
Gnomad FIN
AF:
0.244
Gnomad MID
AF:
0.408
Gnomad NFE
AF:
0.303
Gnomad OTH
AF:
0.288
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.246
AC:
37456
AN:
152188
Hom.:
5213
Cov.:
32
AF XY:
0.242
AC XY:
17989
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.164
AC:
6816
AN:
41510
American (AMR)
AF:
0.256
AC:
3922
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.424
AC:
1471
AN:
3468
East Asian (EAS)
AF:
0.0220
AC:
114
AN:
5184
South Asian (SAS)
AF:
0.209
AC:
1009
AN:
4824
European-Finnish (FIN)
AF:
0.244
AC:
2578
AN:
10586
Middle Eastern (MID)
AF:
0.432
AC:
127
AN:
294
European-Non Finnish (NFE)
AF:
0.303
AC:
20590
AN:
68000
Other (OTH)
AF:
0.289
AC:
611
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1405
2809
4214
5618
7023
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
392
784
1176
1568
1960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.279
Hom.:
865
Bravo
AF:
0.244
Asia WGS
AF:
0.137
AC:
475
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
6.5
DANN
Benign
0.78
PhyloP100
0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2476491; hg19: chr10-6095410; API